The purpose of this project is to determine the natural course of renal disease in type 2 diabetes mellitus in the Pima Indians and to identify the underlying pathogenetic mechanisms involved in the initiation and progression of renal disease in this type of diabetes. This project, in part, represents an extension of work previously reported as Project Number Z01 DK 69037. Glomerular function was measured over a 4-year period in 194 Pima Indians selected to represent stages in the development and progression of diabetic renal disease. Follow-up was extended for an additional 24 months in the 57 subjects with microalbuminuria to characterize the evolution and mechanisms of progressive diabetic glomerular injury. Subjects underwent serial determinations of albuminuria and GFR, and a subset of them underwent morphometric analysis of glomeruli in two biopsies separated by an interval of 48 months. GFR declined by 17% and renal plasma flow by 17% over 60-84 months, regardless of whether or not subjects progressed to macroalbuminuria. Neither glomerular volume nor fractional mesangial volume changed over 48 months, but the prevalence of global glomerulosclerosis doubled and the number of podocytes per glomerulus declined significantly from 547 to 356. Single nephron Kf declined by 20% and was the major determinant of the decline in GFR. Sieving studies in these patients demonstrated no loss of the size-selective barrier in subjects with microalbuminuria, but an abrupt appearance of a shunt at an albumin-to-creatinine ratio of about 3000 mg/g. Shunt size in macroalbuminuric patients correlated with the extent of foot process broadening. These results suggest that although microalbuminuria heralds progressive renal injury, it is not due to defects in the size permselectivity of the glomerular barrier, but rather to changes in either glomerular charge selectivity, tubular handling of filtered proteins, or a combination of these two factors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK069063-05
Application #
6432208
Study Section
(PECR)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2000
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Pavkov, Meda E; Mason, Clinton C; Bennett, Peter H et al. (2009) Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes. Diabetes Care 32:1845-50
Sanchez-Nino, Maria Dolores; Sanz, Ana Belen; Ihalmo, Pekka et al. (2009) The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol 20:353-62
Hanson, Robert L; Craig, David W; Millis, Meredith P et al. (2007) Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56:975-83
Nelson, Robert G; Tuttle, Katherine R (2007) The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD. Blood Purif 25:112-4
Looker, Helen C; Fagot-Campagna, Anne; Gunter, Elaine W et al. (2007) Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetes. Diabetes Metab Res Rev 23:193-201
Otu, Hasan H; Can, Handan; Spentzos, Dimitrios et al. (2007) Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 30:638-43
Shultis, Wendy A; Weil, E Jennifer; Looker, Helen C et al. (2007) Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30:306-11
Nelson, Robert G; Tuttle, Katherine R (2006) NKF releases new KDOQI guidelines for diabetes and CKD. Nephrol News Issues 20:29
Pavkov, M E; Knowler, W C; Bennett, P H et al. (2006) Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int 70:1840-6
Wolford, J K; Yeatts, K A; Red Eagle, A R et al. (2006) Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians. Diabet Med 23:367-76

Showing the most recent 10 out of 25 publications